Maggie is a scientist and science journalist covering health, biology, and bioengineering. She graduated from Harvard College in 2022 with a degree in developmental biology and the history of science. Her writing has appeared in the New York Times, WIRED, Massive Science, and Lady Science. She enjoys watching heart cells beat under a microscope, designing children’s books, and making brunch.
Following innovations in amplification and scaling over the past 30 years, single cell sequencing technologies have permeated all corners of biomedical research, providing cellular insights into diseases such as heart failure or the immune response during COVID-19 infection.
Researchers pioneered a new strategy for diagnosing puzzling genetic diseases, expanding scientists’ capability to study their causes and pathophysiology.
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.